IceCure Medical Announces Presentations, Posters And Physician Workshops On Its ProSense Breast Cancer Cryoablation At The European Society Of Breast Imaging Annual Scientific Meeting

Featured presentations included 12-month clinical data reporting objective response rates of 97.5% among 40 patients treated with cryoablation plus endocrine therapy and 91.7% among 24 patients treated with cryoablation alone.

ProSense® was featured during two key scientific sessions at EUSOBI, reflecting clinical interest in breast cancer cryoablation in Europe. Dr. Lucía Graña-López (Lugo, Spain) presented the clinical potential of cryoablation during her presentation "Beyond Biopsy: Image-Guided Therapy in Practice" during the session "From Target to Treatment: Breast Interventions." Dr. Francesca Pugliese (Florence, Italy) shared her findings from "Local Tumor Control in Elderly Breast Cancer Patients Ineligible for Surgery: Cryoablation Alone or Combined with Hormonal Therapy" during the session on "Advances in Image-Guided Breast Intervention and Minimally Invasive Therapy."

The Company also hosted two well-attended clinical workshops, led by Dr. Lucía Graña-López (Lugo, Spain) and Dr. Federica Di Naro (Florence, Italy): "From Freeze to Future: Cryoablation as a New Frontier in De-Escalated Breast Cancer Care" and "Reading the Freeze: Practical Imaging Interpretation After Breast Cancer Cryoablation". Each workshop attracted nearly 70 participants.

Two scientific posters by ProSense® users were presented: "From Initial Experience to One-Year Outcomes: Single-Center Efficacy and Safety of Percutaneous Cryoablation for Breast Lesions in Romania" by Dr. Georgiana-Cristiana Camen (Romania) and "When Enhancement Disappears: The Role of Negative CEM (Contrast Enhancement Mammography) in Predicting Histological Response After Breast Cryoablation" by Dr. Francesca Pugliese (Florence, Italy).

EUSOBI is a leading European organization dedicated to breast imaging and education, bringing together breast radiologists and other specialists from across Europe and internationally. The Annual Scientific Meeting provides a platform for the exchange of clinical knowledge, research and advances in breast imaging and treatment.